What Is Assembly Biosciences, Inc. (ASMB) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Assembly Biosciences, Inc.'s intrinsic value is estimated at $10.29, suggesting the stock is overvalued at its current price of $26.73. With 8 out of 9 models flagging downside (-61.5% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $25.85 (-3.3%), while ML-RIV — the most conservative — estimates $1.37 (-94.9%). This +91.6% gap reflects genuine analytical uncertainty about Assembly Biosciences, Inc.'s intrinsic worth.
What Do the Models Say About ASMB?
9 of 13 models are currently active for ASMB. All 9 active models suggest the stock trades above fair value. The Bayesian DCF estimates ASMB's intrinsic value at $5.65, implying -78.8% downside from the current price. See which stocks rank higher →
How Does ASMB Rank in Biotechnology?
Among 76 Biotechnology stocks, ASMB ranks #26 by Quality of Company score. CirclFi's QOC score of 5.5/10 evaluates 32 fundamental signals. A score of 5.5 reflects mixed fundamentals.
See all Most Undervalued Biotechnology Stocks →
As a biotech sector, Assembly Biosciences, Inc. operates in a sector where partnership revenue is a critical driver of valuation. Investors evaluating ASMB should weigh these sector-specific dynamics alongside our model-derived fair values.
Is ASMB a Value Trap?
CirclFi's Value Trap algorithm assigns ASMB a score of 38/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for Assembly Biosciences, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Assembly Biosciences, Inc.'s fundamental quality profile registers 5.5/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +91.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every ASMB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across ASMB's 9 active models, average confidence is 27%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad